These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
598 related items for PubMed ID: 23727083
1. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, Subramanian SS, Abdelbaky A, Rudd JH, Farkouh ME, Nunes IO, Beals CR, Shankar SS. J Am Coll Cardiol; 2013 Sep 03; 62(10):909-17. PubMed ID: 23727083 [Abstract] [Full Text] [Related]
2. High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. Subramanian S, Emami H, Vucic E, Singh P, Vijayakumar J, Fifer KM, Alon A, Shankar SS, Farkouh M, Rudd JHF, Fayad ZA, Van Dyke TE, Tawakol A. J Am Coll Cardiol; 2013 Dec 24; 62(25):2382-2391. PubMed ID: 24070911 [Abstract] [Full Text] [Related]
3. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, Tamaki T, Yoshikawa D, Hayashi M, Amano T, Matsubara T, Murohara T. Clin Ther; 2010 Dec 24; 32(14):2337-47. PubMed ID: 21353104 [Abstract] [Full Text] [Related]
4. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. Emami H, Vucic E, Subramanian S, Abdelbaky A, Fayad ZA, Du S, Roth E, Ballantyne CM, Mohler ER, Farkouh ME, Kim J, Farmer M, Li L, Ehlgen A, Langenickel TH, Velasquez L, Hayes W, Tawakol A. Atherosclerosis; 2015 Jun 24; 240(2):490-6. PubMed ID: 25913664 [Abstract] [Full Text] [Related]
5. In vivo evaluation of atherosclerotic plaque inflammation and of anti-inflammatory effects of statins by 18F-fluorodeoxyglucose positron emission tomography. Gerber BL. J Am Coll Cardiol; 2013 Sep 03; 62(10):918-20. PubMed ID: 23727087 [No Abstract] [Full Text] [Related]
6. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point 18F-FDG PET/CT imaging study. Kang MK, Kim CJ, Choo EH, Han EJ, Hwang BH, Kim JJ, Kim SH, O JH, Chang K. Int J Cardiovasc Imaging; 2019 Sep 03; 35(9):1745-1753. PubMed ID: 31312997 [Abstract] [Full Text] [Related]
7. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography. deGoma EM, Salavati A, Shinohara RT, Saboury B, Pollan L, Schoen M, Torigian DA, Mohler ER, Dunbar RL, Litt HI, Woo J, Rader DJ, Alavi A, Mehta NN. Acad Radiol; 2015 May 03; 22(5):600-9. PubMed ID: 25708866 [Abstract] [Full Text] [Related]
8. Atorvastatin Reduces Circulating S100A12 Levels in Patients with Carotid Atherosclerotic Plaques - A Link with Plaque Inflammation. Komatsu T, Ayaori M, Uto-Kondo H, Hayashi K, Tamura K, Sato H, Sasaki M, Nishida T, Takiguchi S, Yakushiji E, Nakaya K, Ikewaki K. J Atheroscler Thromb; 2022 May 01; 29(5):775-784. PubMed ID: 33952812 [Abstract] [Full Text] [Related]
9. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Wu YW, Kao HL, Huang CL, Chen MF, Lin LY, Wang YC, Lin YH, Lin HJ, Tzen KY, Yen RF, Chi YC, Huang PJ, Yang WS. Eur J Nucl Med Mol Imaging; 2012 Mar 01; 39(3):399-407. PubMed ID: 22109668 [Abstract] [Full Text] [Related]
10. Effect of moderate-intensity statin therapy on plaque inflammation in patients with acute coronary syndrome: A prospective interventional study evaluated by 18F-FDG PET/CT of the carotid artery. Kim CJ, Han EJ, Chu EH, Hwang BH, Kim JJ, Seung KB, Kim SH, O JH, Chang K. Cardiol J; 2020 Mar 01; 27(6):762-771. PubMed ID: 30009378 [Abstract] [Full Text] [Related]
11. Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation. Oh M, Kim H, Shin EW, Sung C, Kim DH, Moon DH, Lee CW. BMC Cardiovasc Disord; 2019 Aug 19; 19(1):201. PubMed ID: 31426749 [Abstract] [Full Text] [Related]
12. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Zhao QM, Feng TT, Zhao X, Xu ZM, Liu Y, Li DP, Li LQ, Su G, Zhang XX. Chin Med J (Engl); 2011 Mar 19; 124(6):911-7. PubMed ID: 21518602 [Abstract] [Full Text] [Related]
13. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. Elkhawad M, Rudd JH, Sarov-Blat L, Cai G, Wells R, Davies LC, Collier DJ, Marber MS, Choudhury RP, Fayad ZA, Tawakol A, Gleeson FV, Lepore JJ, Davis B, Willette RN, Wilkinson IB, Sprecher DL, Cheriyan J. JACC Cardiovasc Imaging; 2012 Sep 19; 5(9):911-22. PubMed ID: 22974804 [Abstract] [Full Text] [Related]
14. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. Vucic E, Calcagno C, Dickson SD, Rudd JH, Hayashi K, Bucerius J, Moshier E, Mounessa JS, Roytman M, Moon MJ, Lin J, Ramachandran S, Tanimoto T, Brown K, Kotsuma M, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. JACC Cardiovasc Imaging; 2012 Aug 19; 5(8):819-28. PubMed ID: 22897996 [Abstract] [Full Text] [Related]
15. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JHF, Tawakol A, Farkouh ME, Fayad ZA. JACC Cardiovasc Imaging; 2013 Oct 19; 6(10):1087-1094. PubMed ID: 24135322 [Abstract] [Full Text] [Related]
16. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T. Int J Cardiovasc Imaging; 2016 Jan 19; 32(1):49-59. PubMed ID: 25898891 [Abstract] [Full Text] [Related]
17. Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease. Hoogeveen RM, Verweij SL, Kaiser Y, Kroon J, Verberne HJ, Vogt L, Moens SJB, Stroes ESG. Sci Rep; 2021 Feb 18; 11(1):4126. PubMed ID: 33602971 [Abstract] [Full Text] [Related]
18. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A. J Vis Exp; 2012 May 02; (63):e3777. PubMed ID: 22588186 [Abstract] [Full Text] [Related]
19. Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study. Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina HM, Abdelbaky A, Alon A, Shankar SS, Rudd JH, Fayad ZA, Hoffmann U, Tawakol A. Circ Cardiovasc Imaging; 2016 Dec 02; 9(12):e004195. PubMed ID: 27956407 [Abstract] [Full Text] [Related]
20. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N, Imaizumi T. J Am Coll Cardiol; 2006 Nov 07; 48(9):1825-31. PubMed ID: 17084257 [Abstract] [Full Text] [Related] Page: [Next] [New Search]